Form4insider filings, from the source

SEC Form 4 · accession 0001232524-15-000034

Jazz Pharmaceuticals plc · JAZZ

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Russell J. Cox
Officer — EVP & COO
Period of report
Feb 26, 2015
Accepted (ET)
Mar 2, 2015 · 6:19 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001232524

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Ordinary SharesF2Feb 26, 2015A7,675$0.00A68,072D
Ordinary SharesFeb 27, 2015F948$170.09D67,124D

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Incentive Stock Option (right to buy)F4$175.19Feb 26, 2015A570A—Feb 25, 2025Ordinary Shares570570D
Non-Qualified Stock Option (right to buy)F4$175.19Feb 26, 2015A19,430A—Feb 25, 2025Ordinary Shares19,43019,430D

Explanation of responses